cocaine and glucagon-like peptide 1

cocaine has been researched along with glucagon-like peptide 1 in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	3 (37.50)	2.80

Authors

Authors	Studies
Bugarith, K; Dinh, TT; Li, AJ; Ritter, S; Speth, RC	1
Egecioglu, E; Engel, JA; Jerlhag, E	1
Bouhlal, S; Ellefsen, KN; Gorelick, DA; Huestis, MA; Leggio, L; Pirard, S; Sheskier, MB; Singley, E	1
Gardner, EL; Wang, B; Wise, RA; You, ZB	1
Borner, T; De Jonghe, BC; Hayes, MR; Leon, RM; Schmidt, HD; Stein, LM; Urrutia, NA	1
Angarita, GA; Costeines, JL; Jastreboff, AM; Malison, RT; Matuskey, D; Pittman, B; Potenza, MN; Schmidt, HD	1
Colvin, KJ; Currie, PJ; Dickinson, MB; Engel, L; Fimmel, AI; Halperin, MC; Holland, JG; Kanter, MJ; Killen, HS	1
Golozoubova, V; Gotfredsen, CF; Knudsen, LB; Raun, K; Rolin, B; von Voss, P	1

Trials

1 trial(s) available for cocaine and glucagon-like peptide 1

Article	Year
Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder. Drug and alcohol dependence, 2021, 04-01, Volume: 221 Topics: Adult; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Double-Blind Method; Exenatide; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Islet Amyloid Polypeptide; Male; Middle Aged; Self Administration; Treatment Outcome	2021

Article

Year

Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder.

Drug and alcohol dependence, 2021, 04-01, Volume: 221

Topics: Adult; Cocaine; Cocaine-Related Disorders; Cross-Over Studies; Double-Blind Method; Exenatide; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Islet Amyloid Polypeptide; Male; Middle Aged; Self Administration; Treatment Outcome

2021

Other Studies

7 other study(ies) available for cocaine and glucagon-like peptide 1

Article	Year
Basomedial hypothalamic injections of neuropeptide Y conjugated to saporin selectively disrupt hypothalamic controls of food intake. Endocrinology, 2005, Volume: 146, Issue:3 Topics: Agouti-Related Protein; alpha-MSH; Amphetamines; Animals; Arcuate Nucleus of Hypothalamus; Binding, Competitive; Body Weight; Catecholamines; Cholecystokinin; Cocaine; Dopamine Uptake Inhibitors; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Hypothalamus; Immunohistochemistry; In Situ Hybridization; Inhibitory Concentration 50; Intercellular Signaling Peptides and Proteins; Leptin; Ligands; Male; Models, Biological; Neurons; Neuropeptide Y; Peptide Fragments; Peptide Hormones; Peptides; Plant Proteins; Pro-Opiomelanocortin; Protein Binding; Protein Precursors; Proteins; Rats; Rats, Sprague-Dawley; Rhombencephalon; RNA, Messenger; Thioglycolates; Time Factors; Toxins, Biological	2005
The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice. PloS one, 2013, Volume: 8, Issue:7 Topics: Amphetamine; Animals; Central Nervous System Stimulants; Cocaine; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Liraglutide; Male; Mice; Motor Activity; Peptides; Receptors, Glucagon; Venoms	2013
Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses. Drug and alcohol dependence, 2017, 11-01, Volume: 180 Topics: Cocaine; Eating; Ghrelin; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Insulin; Islet Amyloid Polypeptide; Leptin; Peptide YY	2017
Cocaine and cocaine expectancy increase growth hormone, ghrelin, GLP-1, IGF-1, adiponectin, and corticosterone while decreasing leptin, insulin, GIP, and prolactin. Pharmacology, biochemistry, and behavior, 2019, Volume: 176 Topics: Adiponectin; Animals; Cocaine; Cocaine-Related Disorders; Corticosterone; Disease Models, Animal; Drug Substitution; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon-Like Peptide 1; Growth Hormone; Injections, Intravenous; Insulin; Leptin; Prolactin; Rats; Reward; Saline Solution; Self Administration; Signal Transduction	2019
Activation of PPG neurons following acute stressors differentially involves hindbrain serotonin in male rats. Neuropharmacology, 2021, 04-01, Volume: 187 Topics: Animals; Cocaine; Glucagon-Like Peptide 1; Lithium Chloride; Male; Neural Pathways; Neurons; Nucleus Raphe Magnus; Proglucagon; Proto-Oncogene Proteins c-fos; Raphe Nuclei; Rats; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin, 5-HT3; Rhombencephalon; Serotonergic Neurons; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Solitary Nucleus; Stress, Physiological; Stress, Psychological	2021
Differential effects of intra-ventral tegmental area ghrelin and glucagon-like peptide-1 on the stimulatory action of D-amphetamine and cocaine-induced ethanol intake in male Sprague Dawley rats. Behavioural brain research, 2022, 03-12, Volume: 421 Topics: Alcohol Drinking; Animals; Behavior, Animal; Central Nervous System Depressants; Central Nervous System Stimulants; Cocaine; Dextroamphetamine; Ethanol; Exenatide; Ghrelin; Glucagon-Like Peptide 1; Incretins; Male; Rats; Rats, Sprague-Dawley; Ventral Tegmental Area	2022
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not. Diabetes, 2007, Volume: 56, Issue:1 Topics: Adamantane; Animals; Body Composition; Body Weight; Candy; Energy Intake; Energy Metabolism; Glucagon-Like Peptide 1; Hypoglycemic Agents; Liraglutide; Nitriles; Obesity; Pancreas; Pyrrolidines; Rats; Rats, Sprague-Dawley; Vildagliptin	2007